Skip to content

VIVOS INC.: 10-Q filed 2025-11-12

What VIVOS INC. reported in its quarterly report filed 2025-11-12 (fiscal Q3 2025): 26 published measures, 86 facts as tagged in accession 0001493152-25-021619.

This filing

Form
10-Q (quarterly report)
Filed
2025-11-12
Fiscal period
fiscal Q3 2025
Accession
0001493152-25-021619 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VIVOS INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-09-302,295,185USD
At 2024-12-312,233,456USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-09-30112,693USD
At 2024-12-3186,209USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-09-302,182,492USD
At 2025-06-302,679,098USD
At 2025-03-313,186,489USD
At 2024-12-312,147,247USD
At 2024-09-301,195,505USD
At 2024-06-301,603,105USD
At 2024-03-311,307,563USD
At 2023-12-311,365,120USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-507,294USD92
2025-01-01 to 2025-09-30-1,987,503USD273
2025-04-01 to 2025-06-30-645,513USD91
2025-01-01 to 2025-03-31-834,696USD90
2024-07-01 to 2024-09-30-825,263USD92
2024-01-01 to 2024-09-30-1,887,260USD274
2024-04-01 to 2024-06-30-503,458USD91
2024-01-01 to 2024-03-31-558,539USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-1,518,189USD273
2024-01-01 to 2024-09-30-1,213,127USD274

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2025-07-01 to 2025-09-301,879USD92
2025-01-01 to 2025-09-3043,627USD273
2024-07-01 to 2024-09-305,000USD92
2024-01-01 to 2024-09-3023,000USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-09-301,507,750USD273
2024-01-01 to 2024-09-30839,000USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-09-30-87,348,732USD
At 2024-12-31-85,361,229USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-07-01 to 2025-09-30454,304,627shares92
2025-01-01 to 2025-09-30452,039,124shares273
2024-07-01 to 2024-09-30418,629,728shares92
2024-01-01 to 2024-09-30403,860,277shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-07-01 to 2025-09-30454,304,627shares92
2025-01-01 to 2025-09-30452,039,124shares273
2024-07-01 to 2024-09-30418,629,728shares92
2024-01-01 to 2024-09-30403,860,277shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-07-01 to 2025-09-300USD/shares92
2025-01-01 to 2025-09-300USD/shares273
2024-07-01 to 2024-09-300USD/shares92
2024-01-01 to 2024-09-300USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-07-01 to 2025-09-300USD/shares92
2025-01-01 to 2025-09-300USD/shares273
2024-07-01 to 2024-09-300USD/shares92
2024-01-01 to 2024-09-300USD/shares274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-531,023USD92
2025-01-01 to 2025-09-30-2,069,328USD273
2024-07-01 to 2024-09-30-843,145USD92
2024-01-01 to 2024-09-30-1,942,584USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-09-302,295,185USD
At 2024-12-312,233,456USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-09-30112,693USD
At 2024-12-3186,209USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-09-304,699USD
At 2024-12-3110,326USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-07-01 to 2025-09-30518,208USD92
2025-01-01 to 2025-09-302,012,678USD273
2024-07-01 to 2024-09-30844,226USD92
2024-01-01 to 2024-09-301,944,885USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-09-3062,734USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-12,815USD92
2025-01-01 to 2025-09-30-56,650USD273
2024-07-01 to 2024-09-301,081USD92
2024-01-01 to 2024-09-302,301USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-07-01 to 2025-09-3067,820USD92
2025-01-01 to 2025-09-30295,066USD273
2024-07-01 to 2024-09-3066,551USD92
2024-01-01 to 2024-09-30223,660USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-09-30454,664,957shares
At 2024-12-31440,873,806shares

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-507,294USD92
2025-01-01 to 2025-09-30-1,987,503USD273
2024-07-01 to 2024-09-30-825,263USD92
2024-01-01 to 2024-09-30-1,887,260USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-3072,904USD92
2025-01-01 to 2025-09-30206,021USD273
2024-07-01 to 2024-09-3065,123USD92
2024-01-01 to 2024-09-30143,468USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-07-01 to 2025-09-3023,729USD92
2025-01-01 to 2025-09-3081,825USD273
2024-07-01 to 2024-09-3017,882USD92
2024-01-01 to 2024-09-3055,324USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-5,627USD273
2024-01-01 to 2024-09-30-2,000USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-3062,734USD273

Inspect the source

Entity
VIVOS INC. / CIK 0001449349
Captured
2026-09-20T09:05:12.589Z
SEC response SHA-256
ce4dc150ed258dcd9bdf143d6c062677dd247739f189597fa6576438180f81de

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001449349.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))